Bayer launches pill to treat chronic kidney disease linked to diabetes
The drug, touted as a potential blockbuster drug for the German pharmaceutical firm, will be sold under the brand name Kerendia in India.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Chronic Kidney Disease | Diabetes | Endocrinology | Germany Health | India Health | Pharmaceuticals | Urology & Nephrology